The causal relation between human papillomavirus and cervical cancer, J Clin Pathol, vol.55, pp.244-65, 2002. ,
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, vol.189, pp.12-19, 1999. ,
Estimated cancer incidence, mortality and prevalence worldwide in 2012, p.31, 2016. ,
Chapter 8: screening for cervical cancer in developing countries, Vaccine, vol.24, issue.3, pp.71-77, 2006. ,
, Comprehensive cervical cancer control: a guide to essential practice, p.12, 2014.
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer, Int J Gynaecol Obstet, vol.132, pp.252-260, 2016. ,
Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies, BMJ, vol.351, p.3084, 2015. ,
Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India, Int J Cancer, vol.123, pp.153-60, 2008. ,
Visual inspection methods for cervical cancer prevention, Best Pract Res Clin Obstet Gynaecol, vol.26, pp.221-253, 2012. ,
HPV screening for cervical cancer in rural India, N Engl J Med, vol.360, pp.1385-94, 2009. ,
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, Lancet Oncol, vol.11, pp.1048-56, 2010. ,
Rapid tests for sexually transmitted infections (STIs): the way forward, Sex Transm Infect, vol.82, issue.5, pp.1-6, 2006. ,
On behalf of the WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogenspart B: biological agents, Lancet Oncology, vol.10, pp.321-323, 2009. ,
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, vol.155, pp.529-565, 2011. ,
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews, J Clin Epidemiol, vol.58, pp.982-90, 2005. ,
Quantifying heterogeneity in a meta-analysis, Stat Med, vol.21, pp.1539-58, 2002. ,
A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations, Stat Med, vol.20, pp.2865-84, 2001. ,
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, vol.339, p.2535, 2009. ,
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, vol.283, pp.2008-2020, 2000. ,
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China, Lancet Oncol, vol.9, pp.929-965, 2008. ,
Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria, Int J Cancer, vol.131, pp.2903-2912, 2012. ,
An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China, Cancer Prev Res, vol.6, pp.938-986, 2013. ,
A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and Papanicolaou testing for the detection of cervical cancer, Int J Gynecol Cancer, vol.24, pp.576-85, 2014. ,
Performance of careHPV for detecting highgrade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study, Br J Cancer, vol.115, pp.425-455, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01844576
Clinical performance validation of 4 pointof-care cervical cancer screening tests in HIV-infected women in Zambia, J Low Genit Tract Dis, vol.20, pp.218-241, 2016. ,
Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 methods in diagnosing cervical intraepithelial neoplasia grade 2+ in Xinjiang Uyghur women, Oncologist, vol.21, pp.825-856, 2016. ,
Performance of cervical cancer screening techniques in HIV-infected women in Uganda, J Low Genit Tract Dis, vol.19, pp.215-224, 2015. ,
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer, Vaccine, vol.30, issue.5, pp.88-99, 2012. ,
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?, Clin Microbiol Infect, vol.21, pp.817-843, 2015. ,
Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries, Lancet, p.389, 2017. ,
Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project, Lancet, vol.361, pp.814-834, 2003. ,
Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana, Am J Obstet Gynecol, vol.196, pp.407-408, 2007. ,
Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia, PLoS One, vol.10, p.122169, 2015. ,
Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa, PLoS One, vol.8, p.53494, 2013. ,
HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia, Int J Cancer, vol.130, pp.1387-94, 2012. ,
Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya, Int J Cancer, vol.134, pp.740-745, 2014. ,
Epidemiology of high-risk human papillomavirus and cervical lesions in african women living with HIV/AIDS: effect of anti-retroviral therapy, AIDS, 2016. ,
Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women, J Infect Dis, vol.207, pp.1723-1732, 2013. ,
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis, Lancet Oncol, vol.15, pp.172-83, 2014. ,
Feasibility of community-based careHPV for cervical cancer prevention in rural Thailand, J Low Genit Tract Dis, vol.17, pp.315-324, 2013. ,
Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador, Int J Gynaecol Obstet, vol.126, pp.156-60, 2014. ,
Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women. BMC Women's Health, 2017. ,
Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and uninfected Rwandan women: implications for hrHPV-based screening in Rwanda, Infect Agent Cancer, vol.9, p.40, 2014. ,
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and metaanalysis of non-randomized studies, Gynecol Oncol, vol.104, pp.232-278, 2007. ,
Reliability of the Xpert HPV assay to detect highrisk human papillomavirus DNA in a colposcopy referral population, Am J Clin Pathol, vol.143, pp.126-159, 2015. ,
Performance of a cartridge-based assay for detection of clinically significant human papillomavirus (HPV) infection: lessons from VALGENT (Validation of HPV genotyping tests), group.bmj.com on December 9, vol.54, pp.2337-2379, 2016. ,